- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Lineage Cell Therapeutics (AMEX:LCTX), Quotes and News Summary
Lineage Cell Therapeutics (AMEX: LCTX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.030 | -0.040 | -0.0100 | ||||
| REV | 7.320M | 5.237M | -2.083M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Lineage Cell Therapeutics Questions & Answers
You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.
There are no as such competitors for Lineage Cell Therapeutics.
The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by B. Riley Securities on Tuesday, June 14, 2022. The analyst firm set a price target for 4.00 expecting LCTX to rise to within 12 months (a possible 178.75% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $1.435 last updated June 28, 2022, 7:59 PM UTC.
There are no upcoming dividends for Lineage Cell Therapeutics.
Lineage Cell Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Lineage Cell Therapeutics.
Lineage Cell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.